The C282Y mutation in the haemochromatosis gene (HFE) and hepatitis C virus infection are independent cofactors for porphyria cutanea tarda in Australian patients

Journal of Hepatology

Volumn 28, Issue 3, 1998, Pages 404-409

  Stuart, Katherine A ^a   Busfield, Frances ^a   Jazwinska, Elizabeth C ^a   Gibson, Peter ^a   Butterworth, Lesley A ^a   Cooksley, W Graham ^a   Powell, Lawrie W ^a   Crawford, Darrell H g ^a  

^a ROYAL BRISBANE AND WOMEN'S HOSPITAL   (Australia)

Author keywords

Hepatitis C virus; Hereditary hemochromatosis; HFE; Porphyria cutanea tarda

Indexed keywords

FERRITIN; IRON; TRANSFERRIN;

ADULT; AGED; ALLELE; ARTICLE; AUSTRALIA; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; GENE FREQUENCY; GENE MUTATION; GENETIC SUSCEPTIBILITY; GENOTYPE; HEMOCHROMATOSIS; HEPATITIS C; HEPATITIS C VIRUS; HETEROZYGOSITY; HOMOZYGOSITY; HUMAN; HUMAN TISSUE; IRON STORAGE; MALE; PORPHYRIA CUTANEA TARDA; PRIORITY JOURNAL;

EID: 0032030738     PISSN: 01688278     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0168-8278(98)80313-9     Document Type: Article

References (38)

1. Kappas A, Sassa S, Galbraith RA, Nordmann Y, Valle D. The porphyrias. Scriver CR, Beaudet AL, Sly WS. 7th ed. The Molecular and Metabolic Basis of Inherited Disease. 1995;2103-2159 McGraw-Hill, New York.
2. Habermann HF, Rosenberg L, Menon LA. Porphyria cutanea tarda: comparison of cases precipitated by alcohol and estrogens. Can Med Assoc J. 1113:1975;633-655.
3. Lundvall O, Weinfeld A, Lundin P. Iron storage in porphyria cutanea tarda. Acta Med Scand. 188:1970;37-53.
4. Fargion S, Piperno A, Cappellini MD, Sampietro M, Fracanzani AL, Romano R, et al. Hepatitis C virus and porphyria cutanea tarda: evidence of a strong association. Hepatology. 16:1992;1322-1326.
5. Rocchi E, Gibertini P, Cassanelli M, Pietrangelo A, Jensen J, Ventura E. Hepatitis B virus infection in porphyria cutanea tarda. Liver. 6:1986;153-157.
6. Ippen H. Treatment of porphyria cutanea tarda by phlebotomy. Semin Hematol. 14:1977;253-259.
7. Kushner JP, Edwards CQ, Dadone MM, Skolnick MH. Heterozygosity for HLA-linked haemochromatosis as a likely cause of the hepatic siderosis associated with sporadic porphyria cutanea tarda. Gastroenterology. 88:1985;1232-1238.
8. Edwards CQ, Griffen LM, Goldgar DE, Skolnick MH, Kushner JP. HLA-linked haemochromatosis in sporadic porphyria cutanea tarda. Gastroenterology. 97:1989;972-981.
9. Beaumont C, Fauchet R, Phung LN, De Verneuil H, Gueguen M, Nordmann Y. Porphyria cutanea tarda and HLA-linked haemochromatosis. Evidence against a systematic association. Gastroenterology. 92:1987;1833-1838.
10. Feder JN, Gnirke A, Thomas W, Tsuchihashi Z, Ruddy DA, Basava A, et al. A novel MHC class 1 like gene is mutated in patients with hereditary haemochromatosis. Nat Genet. 13:1996;399-408.
11. Jazwinska EC, Cullen L, Busfield F, Pyper W, Webb S, Powell LW. Scientific correspondence. Nat Genet. 14:1996;249-251.
12. Jouanolle AM, Gandon G, Jezequel P, Blayau M, Campion ML. Haemochromatosis and HLA-H. Nat Genet. 14:1996;251-252.
13. Roberts AG, Whatley SD, Morgan RR, Worwood M, Elder GH. Increased frequency of the haemochromatosis Cys282-Tyr mutation in sporadic porphyria cutanea tarda. Lancet. 349:1997;321-323.
14. Butterworth L, Cooksley WGE. Hepatitis C virus RNA and genotype in multiple hepatitis infections. First Australasian Conference on Hepatitis C. March 1997;. Sydney.
15. DeCastro M, Sanchez J, Herrera JF, Chaves A, Duran R, Garcia-Buey L, et al. Hepatitis C virus antibodies and liver disease in patients with porphyria cutanea tarda. Hepatology. 17:1993;551-557.
16. Navas S, Bosch O, Castillo I, Marriott E, Carreno V. Porphyria cutanea tarda and hepatitis C and B viruses infection: a retrospective study. Hepatology. 21:1995;279-284.
17. Janot C, Courouce AM, Maniez M. Antibodies to hepatitis C virus in French blood donors. Lancet. ii:1989;796-797.
18. Sirchia G, Bellobuono A, Giovanetti A, Marconi M. Antibodies to hepatitis C virus in Italian blood donors. Lancet. ii:1989;797.
19. Esteban JI, Esteban R, Viladomiu L, Lopez-Talavera JL, Gonzalez A, Hernandez J, et al. Hepatitis C virus antibodies among risk groups in Spain. Lancet. ii:1989;294-296.
20. Stolzel U, Kostler E, Koszka C, Stoffler-Meilicke M, Schuppan D, Somasundaram R, et al. Low prevalence of hepatitis C virus infection in porphyria cutanea tarda in Germany. Hepatology. 21:1995;1500-1503.
21. Murphy A, Dooley S, Hillary IB, Murphy GM. HCV infection in porphyria cutanea tarda. [Letter] Lancet. 341:1993;1534-1535.
22. Kuhnl P, Seidl S, Stangel W, Beyer J, Sibrowski W, Flik J. Antibody to hepatitis C virus in German blood donors. Lancet. ii:1989;324.
23. Contreras M, Barabara JAJ. Screening for hepatitis C virus antibody. Lancet. ii:1989;505.
24. Gibson PR, Ratnaike S, Blake D, Sinickas V. Porphyria cutanea tarda and hepatitis C [letter]. Med J Aust. 162:1995;54.
25. Fairley CK, Leslie DE, Nicholson S, Gust ID. Epidemiology and hepatitis C virus in Victoria. Med J Aust. 153:1990;247-249.
26. Fargion S, Fracanzani AL, Romano R, Cappellini MD, Fare M, Mattiolo M, et al. Genetic haemochromatosis in Italian patients with porphyria cutanea tarda: possible explanation for iron overload. J Hepatol. 24:1996;564-569.
27. Beard P, Offord E, Paduwat N, Bruggmann H. SV40 activates transcription from transferrin receptor promoter by inducing a factor which binds to the CRE/AP-1 recognition sequence. Nucleic Acid Res. 19:1991;7117-7123.
28. Merryweather-Clarke AT, Pointon JJ, Shearman JD, Robson KTH. Global prevalence of putative haemochromatosis mutations. J Med Genet. 34:1997;275-278.
29. Cullen LM, Summerville L, Crawford DHG, Powell LW, Jazwinska EC. Population frequency of the haemochromatosis C282Y and H63D mutations. Blood. 1997;. In press.
30. Bassett ML, Halliday JW, Powell LW. Value of hepatic iron measurement in early haemochromatosis and determination of the critical iron level associated with fibrosis. Hepatology. 6:1986;24-29.
31. Scheuer PJ, Williams R, Muir AR. Hepatic pathology in relatives of patients with haemochromatosis. J Pathol Bacteriol. 84:1962;53-64.
32. Summers KM, Halliday JW, Powell LW. Identification of homozygous haemochromatosis subjects by measurement of hepatic iron index. Hepatology. 12:1990;20-25.
33. Young KKY, Resnik RM, Myers TW. Detection of hepatitis C virus RNA by a combined reverse transciptase-polymerase chain reaction assay. J Clin Microbiol. 31:1993;882-886.
34. Stuyver L, Rossau R, Wyseur A, Duhamel M, Vanderborght B, Van Heuverswyn H, et al. Typing of hepatitis C virus isolates and characterisation of new subtypes using a line probe assay. J Gen Virol. 74:1993;1093-1102.
35. Simmonds P, Alberti A, Alter HJ, Bonino F, Bradley DW, Brechot C, et al. A proposed system for the nomenclature of hepatitis C viral genotypes. Hepatology. 19:1994;1321-1324.
36. Makkai C, McAllister I. Patterns of drug use in Australian societies: analysis of national trend data. 1985-1991. Department of Health, Housing, Local Government and Community Services. 1993;25-32 AGPS Dept, Canberra.
37. Crawford DHG, Powell LW, Leggett BA, Francis JS, Fletcher LM, Webb SI, et al. Evidence that the ancestral haplotype may be associated with a common mutation in the HC gene. Am J Hum Genet. 57:1995;362-367.
38. Sampietro M, Fracanzani AL, Corbetta N, Brunetti E, Salvadori S, Molteni V, et al. HCV type 1b in patients with chronic liver diseases and porphyria cutanea tarda [abstract]. Hepatology. 24:1995;350.